sorafenib has been researched along with Lymphoma, T Cell, Peripheral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbarotta, L; Cooper, D; Foss, F; Gibson, JF; Irizarry, D; Lansigan, F; Seropian, S | 1 |
1 other study(ies) available for sorafenib and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphoma.
Topics: Antineoplastic Agents; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Pilot Projects; Protein Kinase Inhibitors; Sorafenib; Treatment Outcome | 2014 |